Health benefits of combined oral contraceptives - a narrative review.

Combined oral contraception (COC) combined oral contraceptive pill (COCP) combined oral contraceptives (COCs) endometrial non-gynaecological disorders ovarian and colorectal cancer ovarian and endocrine symptoms reproductive tract disorders

Journal

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
ISSN: 1473-0782
Titre abrégé: Eur J Contracept Reprod Health Care
Pays: England
ID NLM: 9712127

Informations de publication

Date de publication:
01 Mar 2024
Historique:
medline: 1 3 2024
pubmed: 1 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

This review presents an update of the non-contraceptive health benefits of the combined oral contraceptive pill. We conducted a literature search for (review) articles that discussed the health benefits of combined oral contraceptives (COCs), in the period from 1980 to 2023. We identified 21 subjective and/or objective health benefits of COCs related to (i) the reproductive tract, (ii) non-gynaecological benign disorders and (iii) malignancies. Reproductive tract benefits are related to menstrual bleeding(including anaemia and toxic shock syndrome), dysmenorrhoea, migraine, premenstrual syndrome (PMS), ovarian cysts, Polycystic Ovary Syndrome (PCOS), androgen related symptoms, ectopic pregnancy, hypoestrogenism, endometriosis and adenomyosis, uterine fibroids and pelvic inflammatory disease (PID). Non-gynaecological benefits are related to benign breast disease, osteoporosis, rheumatoid arthritis, multiple sclerosis, asthma and porphyria. Health benefits of COCs related to cancer are lower risks of endometrial cancer, ovarian cancer and colorectal cancer. The use of combined oral contraceptives is accompanied with a range of health benefits, to be balanced against its side-effects and risks. Several health benefits of COCs are a reason for non-contraceptive COC prescription.

Identifiants

pubmed: 38426312
doi: 10.1080/13625187.2024.2317295
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-13

Auteurs

Herjan J T Coelingh Bennink (HJT)

Pantarhei Bioscience, Zeist, The Netherlands.

Femke A M van Gennip (FAM)

Heuvelrug Medical Center, Doorn, The Netherlands.

Mireille G F Gerrits (MGF)

Terminal 4 Communications, Hilversum, The Netherlands.

Jan F M Egberts (JFM)

Terminal 4 Communications, Hilversum, The Netherlands.

Kristina Gemzell-Danielsson (K)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Helena Kopp-Kallner (H)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Classifications MeSH